Transcatheter aortic valve replacement for pure aortic valve regurgitation: “on-label” versus “off-label” use of TAVR devicesBernhard Wernly, Alexander Lauten, P. Christian Schulze et al.|Clinical Research in Cardiology|2019Cited by 69
Global research trends in the medical therapy of pulmonary arterial hypertension 2000–2014C Schreiber, Michael Lichtenauer, Ingrid Pretsch et al.|Pulmonary Pharmacology & Therapeutics|2016Cited by 3
Abstract 17688: Soluble ST2 Concentration Predicts 1-Year Outcome in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI)Bernhard Wernly, Alexander Lauten, Christian Jung et al.|Circulation|2016Cited by 0